TAMSULOSINE Streuli caps ret 0.4 mg 100 pce

7680581700037 CH-58170 G04CA02 05.99.0.
TAMSULOSINE Streuli caps ret 0.4 mg 100 pce
TAMSULOSINE Streuli caps ret 0.4 mg 100 pce
TAMSULOSINE Streuli caps ret 0.4 mg 100 pce
1 / 3
google

Details

Product number
5817001
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 7.3 µg, triethylis citras, talcum, aqua purificata q.s., Kapselhülle: gelatina, E 132, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro capsula.

Articles (1)

Tamsulosin Streuli 0,4 mg, Retardkapseln
Streuli
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/07/2025
Patient information leaflet
Français
09/07/2025
Patient information leaflet
Italien
09/07/2025
Professional SmPC
Allemand
09/07/2025
Professional SmPC
Français
09/07/2025
Professional SmPC
Italien
09/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.4 MG Substance WIZUS
(N/A)
0.367 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
7.3 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 52.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2008

Authorization holder

Streuli Pharma AG

8730 Uznach

Authorization information

Swissmedic authorization number
58170
Drug name
Tamsulosin Streuli 0,4 mg, Retardkapseln
Galenic form
RETK
ATC Code
G04CA02
Authorization status
Z
Dispensation category
B
First authorization
01/02/2008
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
benigne Prostatahyperplasie

Packaging details

Description (FR)
TAMSULOSINE Streuli caps ret 0.4 mg 100 pce
Description (DE)
TAMSULOSIN Streuli Ret Kaps 0.4 mg 100 Stk
Market launch
01/02/2008
Narcotic (BTM)
No

Original drug

Omix Ocas 0.4 mg, Retardtabletten
CHF 16.40
View original

Other packaging sizes

TAMSULOSINE Streuli caps ret 0.4 mg 10 pce
10 KAP
View
TAMSULOSINE Streuli caps ret 0.4 mg 30 pce
30 KAP
View